(NP (NP (ADJP (NN T) (JJ cell-specific)) (JJ negative) (NN regulation)) (PP (IN of) (NP (NP (NN transcription)) (PP (IN of) (NP (DT the) (JJ human) (NN cytokine) (NN IL-4))))) (. .))
(S (NP-SBJ (NP (NN IL-4)) (VP (VBN secreted) (NP (-NONE- *)) (PP (IN by) (NP-LGS (VBN activated) (NN T) (NNS cells))))) (VP (VBZ is) (NP-PRD (NP (DT a) (JJ pleiotropic) (NN cytokine)) (VP (VBG affecting) (NP (NP-COOD (NP (NN growth)) (CC and) (NP (NN differentiation))) (PP (IN of) (NP (NP (JJ diverse) (NN cell) (NNS types)) (PP (JJ such) (IN as) (NP-COOD (NP (NN T) (NNS cells)) (, ,) (NP (NN B) (NNS cells)) (, ,) (CC and) (NP (NN mast) (NNS cells)))))))))) (. .))
(S (NP-SBJ (PRP We)) (VP (VBD investigated) (NP (NP (DT the) (JJ upstream) (JJ regulatory) (NNS elements)) (PP (IN of) (NP (DT the) (JJ human) (NN IL-4) (NN promoter))))) (. .))
(S (NP-SBJ-53 (NP (NP (NP (DT A) (JJ novel) (ADJP (NN T) (JJ cell-specific)) (JJ negative) (JJ regulatory) (NN element)) (PRN (-LRB- -LRB-) (NP (NN NRE)) (-RRB- -RRB-))) (NP (-NONE- *ICH*-52))) (VP (VBN composed) (NP (-NONE- *)) (PP (IN of) (NP (CD two) (JJ protein-binding) (NNS sites))))) (VP (VBD were) (VP (VBN mapped) (NP (-NONE- *-53)) (PP (IN in) (NP (NP (DT the) (JJ 5') (JJ flanking) (NN region)) (PP (IN of) (NP (DT the) (NN IL-4) (NN gene))))) (: :) (NP-COOD-52 (NP (NP (NN -311CTCCCTTCT-303)) (PRN (-LRB- -LRB-) (NP (NN NRE-I)) (-RRB- -RRB-))) (CC and) (NP (NP (NN -288CTTTTTGCTT-TGC-300)) (PRN (-LRB- -LRB-) (NP (NN NRE-II)) (-RRB- -RRB-)))))) (. .))
(S (NP-SBJ-54 (NP-COOD (NP (DT A) (ADJP (NN T) (JJ cell-specific)) (NN protein) (NN Neg-1)) (CC and) (NP (DT a) (JJ ubiquitous) (NN protein) (NN Neg-2))) (VP (VBG binding) (PP (TO to) (NP-COOD (NP (NN NRE-I)) (CC and) (NP (NN NRE-II)))) (, ,) (ADVP (RB respectively)) (, ,))) (VP (VBD were) (VP (VBN identified) (NP (-NONE- *-54)))) (. .))
(S (ADVP (RB Furthermore)) (, ,) (NP-SBJ-55 (DT a) (JJ positive) (JJ regulatory) (NN element)) (VP (VBD was) (VP (VBN found) (NP (-NONE- *-55)) (ADVP (NP (CD 45) (NN bp)) (RB downstream) (PP (IN of) (NP (DT the) (NN NRE)))))) (. .))
(S (NP-SBJ-56 (NP (DT The) (NN enhancer) (NN activity)) (PP (IN of) (NP (DT the) (NN PRE)))) (VP (VBD was) (ADVP (RB completely)) (VP (VBN suppressed) (NP (-NONE- *-56)) (SBAR-TMP (WHADVP-57 (WRB when)) (S (NP-SBJ (DT the) (NN NRE)) (VP (VBD was) (ADJP-PRD (JJ present)) (ADVP (-NONE- *T*-57))))))) (. .))
(S (NP-SBJ (DT These) (NNS data)) (VP (VBP suggest) (SBAR (IN that) (S (NP-SBJ-58 (NN IL-4) (NN promoter) (NN activity)) (VP (VBZ is) (ADVP (RB normally)) (VP (VBN down-regulated) (NP (-NONE- *-58)) (PP (IN by) (NP-LGS (DT an) (NN NRE))) (PP (IN via) (NP (NP (NN repression)) (PP (IN of) (NP (DT the) (NN enhancer) (JJ positive) (JJ regulatory) (NN element)))))))))) (. .))
(S (NP-SBJ (DT These) (NNS data)) (VP (MD may) (VP (VB have) (NP (NP (NNS implications)) (PP (IN for) (NP (NP (DT the) (JJ stringent) (NN control)) (PP (IN of) (NP (NP (NN IL-4) (NN expression)) (PP (IN in) (NP (NN T) (NNS cells)))))))))) (. .))
